Treatment of central pontine myelinolysis with thyrotropin-releasing hormone
被引:12
|
作者:
Zein, ÉF
论文数: 0引用数: 0
h-index: 0
机构:St Joseph Hosp, Dept Internal Med, Beirut, Lebanon
Zein, ÉF
Karaa, SE
论文数: 0引用数: 0
h-index: 0
机构:St Joseph Hosp, Dept Internal Med, Beirut, Lebanon
Karaa, SE
Rollot, F
论文数: 0引用数: 0
h-index: 0
机构:St Joseph Hosp, Dept Internal Med, Beirut, Lebanon
Rollot, F
Blanche, P
论文数: 0引用数: 0
h-index: 0
机构:
St Joseph Hosp, Dept Internal Med, Beirut, LebanonSt Joseph Hosp, Dept Internal Med, Beirut, Lebanon
Blanche, P
[1
]
Chemaly, RE
论文数: 0引用数: 0
h-index: 0
机构:St Joseph Hosp, Dept Internal Med, Beirut, Lebanon
Chemaly, RE
机构:
[1] St Joseph Hosp, Dept Internal Med, Beirut, Lebanon
[2] St Joseph Hosp, Med Ctr, Beirut, Lebanon
[3] St Joseph Hosp, Internal Med & Intens Care Dept, Beirut, Lebanon
[4] St Joseph Univ, Beirut, Lebanon
[5] Cochin Univ Hosp, Dept Internal Med, Paris, France
来源:
PRESSE MEDICALE
|
2006年
/
35卷
/
04期
关键词:
D O I:
10.1016/S0755-4982(06)74651-6
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Introduction > Centrolpontine myelinolysis (CPM), demyelination of the brain stem, is a brain injury apparently due to osmotic forces. There is no consensus for its treatment. Case > We describe here a case of CPM that occurred in a young patient after correction of hyponatremia, its treatment by intravenous thyrotropin-releasing hormone, and its outcome. Discussion > Although very few instances of thyrotropin-releasing hormone treatment for CPM have been described, it appears to be effective and well tolerated. Studies are needed to assess its real efficacy.
机构:Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA
Vella, Kristen R.
Hollenberg, Anthony N.
论文数: 0引用数: 0
h-index: 0
机构:
Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USABeth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA